Aion Therapeutic Inc. is a listed company. Its insiders report their share dealings to SEDI. Nothing new has been filed by managers of Aion Therapeutic Inc. in twelve months, the latest record being from 29 April 2024.
Looking back to 2022, when coverage begins, insiders filed no purchases and 8 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
9 of 9 declarations
Aion Therapeutic Inc. is a company focused on developing innovative therapeutic solutions. It is listed on the Toronto Stock Exchange (XTSE).